Fulgent Genetics Quarterly Income Statements Chart
Quarterly
|
Annual
Fulgent Genetics Quarterly Income Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 81,803,000 | 73,463,000 | 76,214,000 | 71,743,000 | 71,028,000 | 64,485,000 | 70,505,000 | 84,687,000 | 67,853,000 | 66,168,000 | 67,704,000 | 105,655,000 | 125,341,000 | 320,268,000 | 251,671,000 | 227,868,000 | 153,616,000 | 359,429,000 | 294,978,000 | 101,716,000 | 17,265,000 | 7,753,000 | 8,387,000 | 10,347,000 | 8,424,000 | 5,370,000 | 5,673,000 | 5,625,000 | 5,400,000 | 4,653,000 | 4,281,000 | 4,503,000 | 4,640,000 | 5,306,000 | 5,854,000 | 5,011,000 |
yoy | 15.17% | 13.92% | 8.10% | -15.28% | 4.68% | -2.54% | 4.14% | -19.85% | -45.87% | -79.34% | -73.10% | -53.63% | -18.41% | -10.90% | -14.68% | 124.02% | 789.75% | 4536.00% | 3417.09% | 883.05% | 104.95% | 44.38% | 47.84% | 83.95% | 56.00% | 15.41% | 32.52% | 24.92% | 16.38% | -12.31% | -26.87% | -10.14% | ||||
qoq | 11.35% | -3.61% | 6.23% | 1.01% | 10.15% | -8.54% | -16.75% | 24.81% | 2.55% | -2.27% | -35.92% | -15.71% | -60.86% | 27.26% | 10.45% | 48.34% | -57.26% | 21.85% | 190.00% | 489.15% | 122.69% | -7.56% | -18.94% | 22.83% | 56.87% | -5.34% | 0.85% | 4.17% | 16.05% | 8.69% | -4.93% | -2.95% | -12.55% | -9.36% | 16.82% | |
cost of revenue | 47,368,000 | 45,117,000 | 44,365,000 | 44,972,000 | 44,537,000 | 42,381,000 | 45,276,000 | 44,843,000 | 47,281,000 | 47,357,000 | 54,717,000 | 59,560,000 | 60,065,000 | 77,725,000 | 62,134,000 | 43,466,000 | 35,858,000 | 74,075,000 | 51,772,000 | 26,261,000 | 7,717,000 | 4,057,000 | 3,634,000 | 3,885,000 | 3,620,000 | 2,968,000 | 2,769,000 | 2,612,000 | 2,544,000 | 2,772,000 | 2,545,000 | 2,268,000 | 1,879,000 | 1,859,000 | 1,864,000 | 2,143,000 |
gross profit | 34,435,000 | 28,346,000 | 31,849,000 | 26,771,000 | 26,491,000 | 22,104,000 | 25,229,000 | 39,844,000 | 20,572,000 | 18,811,000 | 12,987,000 | 46,095,000 | 65,276,000 | 242,543,000 | 189,537,000 | 184,402,000 | 117,758,000 | 285,354,000 | 243,206,000 | 75,455,000 | 9,548,000 | 3,696,000 | 4,753,000 | 6,462,000 | 4,804,000 | 2,402,000 | 2,904,000 | 3,013,000 | 2,856,000 | 1,881,000 | 1,736,000 | 2,235,000 | 2,761,000 | 3,447,000 | 3,990,000 | 2,868,000 |
yoy | 29.99% | 28.24% | 26.24% | -32.81% | 28.77% | 17.51% | 94.26% | -13.56% | -68.48% | -92.24% | -93.15% | -75.00% | -44.57% | -15.00% | -22.07% | 144.39% | 1133.33% | 7620.62% | 5016.89% | 1067.67% | 98.75% | 53.87% | 63.67% | 114.47% | 68.21% | 27.70% | 67.28% | 34.81% | 3.44% | -45.43% | -56.49% | -22.07% | ||||
qoq | 21.48% | -11.00% | 18.97% | 1.06% | 19.85% | -12.39% | -36.68% | 93.68% | 9.36% | 44.84% | -71.83% | -29.38% | -73.09% | 27.97% | 2.78% | 56.59% | -58.73% | 17.33% | 222.32% | 690.27% | 158.33% | -22.24% | -26.45% | 34.51% | 100.00% | -17.29% | -3.62% | 5.50% | 51.83% | 8.35% | -22.33% | -19.05% | -19.90% | -13.61% | 39.12% | |
gross margin % | 42.10% | 38.59% | 41.79% | 37.32% | 37.30% | 34.28% | 35.78% | 47.05% | 30.32% | 28.43% | 19.18% | 43.63% | 52.08% | 75.73% | 75.31% | 80.92% | 76.66% | 79.39% | 82.45% | 74.18% | 55.30% | 47.67% | 56.67% | 62.45% | 57.03% | 44.73% | 51.19% | 53.56% | 52.89% | 40.43% | 40.55% | 49.63% | 59.50% | 64.96% | 68.16% | 57.23% |
operating expenses | ||||||||||||||||||||||||||||||||||||
research and development | 13,480,000 | 12,395,000 | 12,113,000 | 11,783,000 | 13,486,000 | 11,434,000 | 11,952,000 | 10,014,000 | 9,692,000 | 9,782,000 | 8,509,000 | 7,507,000 | 6,905,000 | 5,989,000 | 7,464,000 | 6,021,000 | 5,312,000 | 5,422,000 | 4,576,000 | 3,177,000 | 1,849,000 | 1,978,000 | 1,795,000 | 1,744,000 | 1,574,000 | 1,424,000 | 1,426,000 | 1,438,000 | 1,212,000 | 1,458,000 | 1,324,000 | 1,128,000 | 920,000 | 851,000 | 819,000 | 1,523,000 |
selling and marketing | 12,286,000 | 8,465,000 | 9,538,000 | 9,124,000 | 8,595,000 | 8,989,000 | 10,500,000 | 10,161,000 | 10,723,000 | 10,083,000 | 10,253,000 | 9,859,000 | 10,866,000 | 7,940,000 | 8,200,000 | 6,012,000 | 5,219,000 | 5,008,000 | 5,081,000 | 5,014,000 | 3,260,000 | 1,597,000 | 1,635,000 | 1,687,000 | 1,304,000 | 1,272,000 | 1,128,000 | 1,115,000 | 1,279,000 | 1,130,000 | 1,080,000 | 1,383,000 | 851,000 | 891,000 | 798,000 | 893,000 |
general and administrative | 26,392,000 | 25,291,000 | 24,341,000 | 20,950,000 | 21,326,000 | 21,489,000 | 31,706,000 | 17,498,000 | 17,993,000 | 21,802,000 | 28,793,000 | 26,266,000 | 30,240,000 | 25,775,000 | 22,102,000 | 12,299,000 | 8,329,000 | 8,002,000 | 7,640,000 | 3,741,000 | 1,799,000 | 2,035,000 | 1,732,000 | 1,522,000 | 1,631,000 | 1,529,000 | 1,379,000 | 1,306,000 | 1,366,000 | 1,487,000 | 1,402,000 | 1,205,000 | 1,140,000 | 1,486,000 | 1,115,000 | 1,147,000 |
amortization of intangible assets | 1,990,000 | 1,990,000 | 1,992,000 | 1,993,000 | 1,990,000 | 1,990,000 | 1,958,000 | 1,957,000 | 1,962,000 | 1,968,000 | 2,010,000 | 2,006,000 | 1,575,000 | 906,000 | ||||||||||||||||||||||
total operating expenses | 54,148,000 | 48,141,000 | 47,984,000 | 43,850,000 | 45,397,000 | 43,902,000 | 176,350,000 | 39,630,000 | 40,370,000 | 43,635,000 | 49,539,000 | 45,743,000 | 52,482,000 | 40,610,000 | 38,677,000 | 25,129,000 | 18,860,000 | 18,432,000 | 17,297,000 | 11,932,000 | 6,908,000 | 5,610,000 | 5,162,000 | 4,953,000 | 4,509,000 | 4,225,000 | 3,933,000 | 3,859,000 | 3,857,000 | 4,075,000 | 3,806,000 | 3,716,000 | 2,911,000 | 3,228,000 | 2,732,000 | 3,563,000 |
operating income | -19,713,000 | -19,795,000 | -16,135,000 | -17,079,000 | -18,906,000 | -21,798,000 | -151,121,000 | 214,000 | -19,798,000 | -24,824,000 | -36,552,000 | 352,000 | 12,794,000 | 201,933,000 | 150,860,000 | 159,273,000 | 98,898,000 | 266,922,000 | 225,909,000 | 63,523,000 | 2,640,000 | -1,914,000 | -409,000 | 1,509,000 | 295,000 | -1,823,000 | -1,029,000 | -846,000 | -1,001,000 | -2,194,000 | -2,070,000 | -1,481,000 | -150,000 | 219,000 | 1,258,000 | -695,000 |
yoy | 4.27% | -9.19% | -89.32% | -8080.84% | -4.51% | -12.19% | 313.44% | -39.20% | -254.74% | -112.29% | -124.23% | -99.78% | -87.06% | -24.35% | -33.22% | 150.73% | 3646.14% | -14045.77% | -55334.47% | 4109.61% | 794.92% | 4.99% | -60.25% | -278.37% | -129.47% | -16.91% | -50.29% | -42.88% | 567.33% | -1101.83% | -264.55% | 113.09% | ||||
qoq | -0.41% | 22.68% | -5.53% | -9.66% | -13.27% | -85.58% | -70717.29% | -101.08% | -20.25% | -32.09% | -10484.09% | -97.25% | -93.66% | 33.85% | -5.28% | 61.05% | -62.95% | 18.15% | 255.63% | 2306.17% | -237.93% | 367.97% | -127.10% | 411.53% | -116.18% | 77.16% | 21.63% | -15.48% | -54.38% | 5.99% | 39.77% | 887.33% | -168.49% | -82.59% | -281.01% | |
operating margin % | -24.10% | -26.95% | -21.17% | -23.81% | -26.62% | -33.80% | -214.34% | 0.25% | -29.18% | -37.52% | -53.99% | 0.33% | 10.21% | 63.05% | 59.94% | 69.90% | 64.38% | 74.26% | 76.59% | 62.45% | 15.29% | -24.69% | -4.88% | 14.58% | 3.50% | -33.95% | -18.14% | -15.04% | -18.54% | -47.15% | -48.35% | -32.89% | -3.23% | 4.13% | 21.49% | -13.87% |
other income | 46,000 | 68,000 | 7,000 | 544,000 | ||||||||||||||||||||||||||||||||
interest income | 8,091,000 | 8,018,000 | 8,123,000 | 8,090,000 | ||||||||||||||||||||||||||||||||
interest expense | -17,000 | -14,000 | -40,000 | -14,000 | ||||||||||||||||||||||||||||||||
impairment loss | -9,926,000 | |||||||||||||||||||||||||||||||||||
total other income | -1,806,000 | 8,072,000 | 8,090,000 | -1,453,000 | ||||||||||||||||||||||||||||||||
income before income taxes | -21,519,000 | -11,723,000 | -8,045,000 | -18,532,000 | -11,214,000 | -14,173,000 | -7,222,250 | 6,860,000 | -14,700,000 | -21,049,000 | 201,978,000 | 338,000 | 1,316,000 | -690,000 | ||||||||||||||||||||||
benefit from income taxes | -2,263,000 | 176,000 | -2,124,000 | -327,000 | -10,862,000 | 20,326,000 | -9,386,000 | 414,000 | 2,653,000 | 48,421,000 | 47,148,000 | 37,545,000 | 23,589,000 | 66,513,000 | 58,571,000 | 14,526,000 | -599,000 | 34,000 | -38,000 | 61,000 | 7,000 | 13,000 | 888,000 | -318,000 | -100,000 | -434,000 | -596,000 | -415,000 | -110,000 | 106,000 | 503,000 | 417,000 | ||||
net income from consolidated operations | -19,256,000 | -11,899,000 | -6,190,000 | -14,694,000 | -9,090,000 | -13,846,000 | -134,334,000 | -13,466,000 | -11,590,000 | -15,849,000 | -24,076,000 | 1,343,000 | 11,099,000 | 153,557,000 | 103,677,000 | 122,224,000 | 79,647,000 | |||||||||||||||||||
net income attributable to noncontrolling interests | 299,000 | 369,000 | 302,000 | 46,000 | 380,000 | 384,000 | 6,185,000 | 359,000 | 361,000 | 509,000 | 244,000 | 376,000 | 438,000 | 422,000 | 662,000 | 298,000 | 165,000 | |||||||||||||||||||
net income attributable to fulgent | -18,957,000 | -11,530,000 | -5,888,000 | -14,648,000 | -8,710,000 | -13,462,000 | -128,149,000 | -13,107,000 | -11,229,000 | -15,340,000 | -23,832,000 | 1,719,000 | 11,537,000 | 153,979,000 | 104,339,000 | 122,522,000 | 79,812,000 | |||||||||||||||||||
net income per common share attributable to fulgent | ||||||||||||||||||||||||||||||||||||
basic | -620 | -370 | -190 | -480 | -290 | -450 | -4,300 | -440 | -380 | -520 | -770 | 60 | 380 | 5,090 | 3,460 | 4,130 | 2,740 | 6,960 | 7,240 | 2,110 | 150 | -90 | -10 | 80 | 20 | -100 | -50 | -30 | -60 | -110 | ||||||
diluted | -620 | -370 | -190 | -480 | -290 | -450 | -4,300 | -440 | -380 | -520 | -750 | 60 | 370 | 4,930 | 3,340 | 3,930 | 2,590 | 6,520 | 6,840 | 1,980 | 140 | -90 | -10 | 80 | 20 | -100 | -50 | -30 | -60 | -110 | ||||||
weighted-average common shares: | ||||||||||||||||||||||||||||||||||||
basic | 30,544,000 | 30,832,000 | 30,235,000 | 30,416,000 | 30,098,000 | 29,769,000 | 29,784,000 | 30,013,000 | 29,813,000 | 29,536,000 | 30,097,000 | 30,174,000 | 30,362,000 | 30,234,000 | 29,408,000 | 29,673,000 | 29,150,000 | 28,831,000 | 22,694,000 | 22,062,000 | 21,747,000 | 21,566,000 | 18,709,000 | 18,501,000 | 18,343,000 | 18,228,000 | 18,012,000 | 17,919,000 | 17,864,000 | 17,752,000 | 17,711,000 | 17,676,000 | ||||
diluted | 30,544,000 | 30,832,000 | 30,235,000 | 30,416,000 | 30,098,000 | 29,769,000 | 29,784,000 | 30,013,000 | 29,813,000 | 29,536,000 | 30,964,000 | 30,867,000 | 31,189,000 | 31,240,000 | 30,976,000 | 31,170,000 | 30,830,000 | 30,770,000 | 24,056,000 | 23,539,000 | 22,920,000 | 21,566,000 | 18,709,000 | 19,456,000 | 19,021,000 | 18,228,000 | 18,012,000 | 17,919,000 | 17,864,000 | 17,752,000 | 17,711,000 | 18,178,000 | ||||
operating expenses: | ||||||||||||||||||||||||||||||||||||
impairment of available-for-sale debt securities | -10,073,000 | |||||||||||||||||||||||||||||||||||
(benefit from) benefit from income taxes | -1,855,000 | -3,838,000 | -3,110,000 | -5,200,000 | ||||||||||||||||||||||||||||||||
interest and other income | 7,692,000 | 7,625,000 | 5,925,000 | 6,646,000 | 5,098,000 | 3,775,000 | 3,090,000 | 1,405,000 | 958,000 | 45,000 | -35,000 | 496,000 | 604,000 | 282,000 | 589,000 | 421,000 | 275,000 | 241,000 | 249,000 | 189,000 | 192,000 | 207,000 | 98,000 | 143,000 | 98,000 | 95,000 | 97,000 | 145,000 | 120,000 | 119,000 | 58,000 | 5,000 | ||||
net income per common share attributable to fulgent: | ||||||||||||||||||||||||||||||||||||
basic | -620 | -370 | -190 | -480 | -290 | -450 | -4,300 | -440 | -380 | -520 | -770 | 60 | 380 | 5,090 | 3,460 | 4,130 | 2,740 | 6,960 | 7,240 | 2,110 | 150 | -90 | -10 | 80 | 20 | -100 | -50 | -30 | -60 | -110 | ||||||
diluted | -620 | -370 | -190 | -480 | -290 | -450 | -4,300 | -440 | -380 | -520 | -750 | 60 | 370 | 4,930 | 3,340 | 3,930 | 2,590 | 6,520 | 6,840 | 1,980 | 140 | -90 | -10 | 80 | 20 | -100 | -50 | -30 | -60 | -110 | ||||||
restructuring costs | -26,000 | 105,000 | 2,896,000 | |||||||||||||||||||||||||||||||||
income before income taxes and gain on equity method investment | 54,371,750 | 1,757,000 | 13,752,000 | |||||||||||||||||||||||||||||||||
income before gain on equity method investment | 41,499,750 | 1,343,000 | 11,099,000 | |||||||||||||||||||||||||||||||||
gain on equity method investment | 3,734,000 | |||||||||||||||||||||||||||||||||||
amortization of acquisition-related intangible assets | 199,250 | 797,000 | ||||||||||||||||||||||||||||||||||
income before income taxes, gain on equity method investments and equity loss in investee | 131,618,750 | 159,769,000 | ||||||||||||||||||||||||||||||||||
income before gain on equity method investments and equity loss in investee | 99,707,000 | 122,224,000 | ||||||||||||||||||||||||||||||||||
gain on equity-method investments | ||||||||||||||||||||||||||||||||||||
equity loss in investee | 143,000 | -189,000 | -193,000 | -249,000 | -174,000 | -175,000 | -149,000 | -279,000 | -234,000 | -210,000 | -246,000 | -245,000 | -247,000 | -172,000 | ||||||||||||||||||||||
income before income taxes, gain on equity method investment and equity loss in investee | 99,502,000 | |||||||||||||||||||||||||||||||||||
income before gain on equity method investment and equity loss in investee | 75,913,000 | |||||||||||||||||||||||||||||||||||
income before income taxes and equity loss in investee | 267,204,000 | 2,915,000 | -1,673,000 | -160,000 | 1,698,000 | 487,000 | -1,616,000 | -931,000 | -703,000 | -903,000 | -2,099,000 | -1,973,000 | -1,336,000 | |||||||||||||||||||||||
income before equity loss in investee | 200,691,000 | 3,514,000 | -1,707,000 | -122,000 | 1,637,000 | 480,000 | -1,629,000 | -1,819,000 | -385,000 | -803,000 | -1,665,000 | -1,377,000 | -921,000 | |||||||||||||||||||||||
net income | 200,691,000 | 166,307,000 | 46,638,000 | 3,321,000 | -1,956,000 | -296,000 | 1,462,000 | 331,000 | -1,908,000 | -2,053,000 | -595,000 | -1,049,000 | -1,910,000 | -1,624,000 | -1,093,000 | -25,000 | 232,000 | 813,000 | -1,107,000 | |||||||||||||||||
yoy | -10360.28% | -56284.80% | 3090.01% | 903.32% | 2.52% | -85.58% | -345.71% | -131.55% | -0.10% | 26.42% | -45.56% | 4096.00% | -923.28% | -299.75% | -1.26% | |||||||||||||||||||||
qoq | 20.68% | 256.59% | 1304.34% | -269.79% | 560.81% | -120.25% | 341.69% | -117.35% | -7.06% | 245.04% | -43.28% | -45.08% | 17.61% | 48.58% | 4272.00% | -110.78% | -71.46% | -173.44% | ||||||||||||||||||
net income margin % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 55.84% | 56.38% | 45.85% | 19.24% | -25.23% | -3.53% | 14.13% | 3.93% | -35.53% | -36.19% | -10.58% | -19.43% | -41.05% | -37.94% | -24.27% | -0.54% | 4.37% | 13.89% | -22.09% |
net income per common share: | ||||||||||||||||||||||||||||||||||||
basic | -620 | -370 | -190 | -480 | -290 | -450 | -4,300 | -440 | -380 | -520 | -770 | 60 | 380 | 5,090 | 3,460 | 4,130 | 2,740 | 6,960 | 7,240 | 2,110 | 150 | -90 | -10 | 80 | 20 | -100 | -50 | -30 | -60 | -110 | ||||||
diluted | -620 | -370 | -190 | -480 | -290 | -450 | -4,300 | -440 | -380 | -520 | -750 | 60 | 370 | 4,930 | 3,340 | 3,930 | 2,590 | 6,520 | 6,840 | 1,980 | 140 | -90 | -10 | 80 | 20 | -100 | -50 | -30 | -60 | -110 | ||||||
income before income taxes, equity loss in investee and impairment loss | 226,498,000 | 63,944,000 | ||||||||||||||||||||||||||||||||||
income before equity loss in investee and impairment loss | 167,927,000 | 49,418,000 | ||||||||||||||||||||||||||||||||||
impairment loss in equity-method investment | -647,750 | -2,591,000 | ||||||||||||||||||||||||||||||||||
income from continuing operations | -1,624,000 | -1,093,000 | -25,000 | 232,000 | 813,000 | -1,107,000 | ||||||||||||||||||||||||||||||
income from discontinued operations | ||||||||||||||||||||||||||||||||||||
continuing operations: | ||||||||||||||||||||||||||||||||||||
income per common share: | ||||||||||||||||||||||||||||||||||||
basic | -12.5 | -60 | 0 | 10 | ||||||||||||||||||||||||||||||||
diluted | -12.5 | -60 | 0 | 10 | ||||||||||||||||||||||||||||||||
income before income taxes and equity in net income of affiliate | -30,000 | |||||||||||||||||||||||||||||||||||
income before equity in net income of affiliate | 80,000 | |||||||||||||||||||||||||||||||||||
equity in net income of affiliate | -105,000 | |||||||||||||||||||||||||||||||||||
basic and diluted income per common share: | ||||||||||||||||||||||||||||||||||||
continuing operations—common stock | 170 | -440 | ||||||||||||||||||||||||||||||||||
weighted-average common shares—outstanding—basic and diluted | 13,710,000 | 12,846,000 |
We provide you with 20 years income statements for Fulgent Genetics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Fulgent Genetics stock. Explore the full financial landscape of Fulgent Genetics stock with our expertly curated income statements.
The information provided in this report about Fulgent Genetics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.